In Wednesday trading, the First Trust NYSE Arca Biotechnology Index Fund ETF experienced significant gains, rising approximately 2.2%. Key contributors to this uptick included shares of Neurocrine Biosciences and Incyte, both of which saw an increase of about 6.2%.
Conversely, the Global X Uranium ETF underperformed, declining about 5.7% in the same trading session. Notably, shares of Nano Nuclear Energy dropped by approximately 15.4%, while Nuscale Power fell by around 12.7%.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
